NCT02897375
- Conditions
- Adnexal Diseases, Bladder Cancer, Breast Diseases, +60 more
- Locations
-
- Emory University/Winship Cancer Institute Atlanta, Georgia, United States
Clinical trial condition
Bladder Cancer
Explore clinical trials studying Bladder Cancer. Study availability and eligibility vary by location and protocol.
771 public trials
174 recruiting studies
Bladder Cancer trial results
NCT04534309
- Conditions
- Biliary Tract Diseases, Biliary Tract Neoplasms, Bladder Cancer, +53 more
- Locations
-
- Johns Hopkins ProHealth Baltimore, Maryland, United States
NCT02643043
- Conditions
- Bladder Cancer, Cancer of the Ureter, Carcinoma, +20 more
- Locations
-
- University of Southern Cailfornia Los Angeles, California, United States
- University of Chicago Medical Center Chicago, Illinois, United States
- Johns Hopkins Sidney Kimmel Comprehensive Cancer Center Baltimore, Maryland, United States
- Ichan School of Medicine at Mount Sinai New York, United States
Completed
Hypotension Prediction Effect on AKI
NCT04994639
- Conditions
- Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
- Locations
-
- Ewha Womans University Mokdong Hospital Seoul, South Korea
Completed
Methadone in Cystectomy Patients
NCT04475029
- Conditions
- Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +19 more
- Locations
-
- Aarhus University Hospital Aarhus, Denmark
NCT03636256
- Conditions
- Bladder Cancer, Cancer of the Bladder, Carcinoma, +20 more
- Locations
-
- BCG Oncology, PC Phoenix, Arizona, United States
- James Buchanan Brady Urological Institute, Johns Hopkins Medical Institutions Baltimore, Maryland, United States
- Columbia University Herbert Irving Comprehensive Cancer Center New York, United States
- Carolina Urologic Research Center Myrtle Beach, South Carolina, United States
Completed
Neutrophil-to-Lymphocyte Ratio in Bladder Cancer: A Secondary Biomarker Analysis of SWOG 8710
NCT02756637
- Conditions
- Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
- Locations
-
- Abramson Cancer Center of the University of Pennsylvania Philadelphia, Pennsylvania, United States
Completed
OGX-011 and Docetaxel in Treating Patients With Metastatic or Locally Recurrent Solid Tumors
NCT00471432
- Conditions
- Adenocarcinoma, Adnexal Diseases, Bladder Cancer, +49 more
- Locations
-
Not specified
NCT03602079
- Conditions
- Adenocarcinoma, Adnexal Diseases, Bile Duct Cancer, +129 more
- Locations
-
- Florida Cancer Specialists & Research Institute Sarasota, Florida, United States
- Beth Israel Deaconess Medical Center Cancer Center Boston, Massachusetts, United States
- Karmanos Cancer Institute Detroit, Michigan, United States
- Clinical Research Alliance, Inc. Lake Success, New York, United States
Completed
Vicinium Treatment for Subjects With Non-muscle Invasive Bladder Cancer Previously Treated With BCG
NCT02449239
- Conditions
- Bladder Cancer, Carcinoma, Female Urogenital Diseases, +13 more
- Locations
-
- Birmingham, Alabama, United States
- Phoenix, Arizona, United States
- Tucson, Arizona, United States
- Little Rock, Arkansas, United States